Many studies, preclinical and clinical, show the ability of intranasal insulin to improve cognition and memory in age-related cognitive deficits (summarized in [51]) and neurodevelopmental disorders [52], in particular in children suffering from 22q13 deletion syndrome, which is associated with cognitive impairments and autistic behavior [53]. This evidence concerns the gene INS and neurodevelopmental disorder.